FDA Moves To Crack Down On Unapproved Oxycodone

Law360, New York (July 5, 2012, 8:42 PM EDT) -- The Food and Drug Administration said Thursday it will begin taking enforcement action against the makers of unapproved oxycodone pain medication, three years after it sent warning letters about the drugs to manufacturers.

The FDA said it knows that unapproved, single-ingredient, immediate-release oxycodone, both in tablets and oral solution, is currently being made and sold in the U.S. and could be a danger to patients.

Oxycodone is an extremely popular painkiller. Americans spent $2.9 billion on the approved extended-release drug Oxycontin, made by Purdue Pharma, in...
To view the full article, register now.